NASDAQ:BKYI BIO-key International (BKYI) Stock Forecast, Price & News $0.55 +0.03 (+5.81%) (As of 09/27/2023 ET) Add Compare Share Share Today's Range$0.52▼$0.5550-Day Range$0.48▼$0.7552-Week Range$0.46▼$1.70Volume4,429 shsAverage Volume18,689 shsMarket Capitalization$5.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About BIO-key International (NASDAQ:BKYI) StockBIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.Read More BKYI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BKYI Stock News HeadlinesSeptember 15, 2023 | finance.yahoo.comInsider Buying: BIO-key International Inc Chairman Michael Depasquale Acquires 5,100 SharesSeptember 13, 2023 | finance.yahoo.comInsider Buying: SVP Strategy & Compliance James Sullivan Acquires 9,000 Shares of BIO-key ...September 27, 2023 | Behind the Markets (Ad)How A.I. Could Make Most 21st Century Diseases EXTINCTOn December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...September 7, 2023 | baystreet.caBIO-Key Accepted by Amazon Web ServicesSeptember 7, 2023 | finance.yahoo.comBIO-key International Joins AWS ISV Accelerate Program to Elevate Biometric Security Solutions on AWSAugust 31, 2023 | finance.yahoo.comIdentity and Access Management Provider BIO-key to Participate at H.C. Wainwright Investment Conference in New York City, Sept. 11th & 12thAugust 31, 2023 | finance.yahoo.comIdentity and Access Management Provider BIO-key to Participate at H.C. Wainwright Investment Conference in New York City, Sept. 11th & 12thAugust 16, 2023 | finance.yahoo.comQ2 2023 BIO-Key International Inc Earnings CallSeptember 27, 2023 | Tradewins (Ad)The Safest Option in Trades!If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult. And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves! August 13, 2023 | benzinga.comBIO-key Intl's Earnings OutlookAugust 8, 2023 | finance.yahoo.comIdentity and Access Management, Cybersecurity Solutions Provider BIO-key International Hosts Q2 Conference Call Tue. Aug. 15 at 10am ETAugust 8, 2023 | finance.yahoo.comIdentity and Access Management, Cybersecurity Solutions Provider BIO-key International Hosts Q2 Conference Call Tue. Aug. 15 at 10am ETAugust 8, 2023 | finance.yahoo.comLeading Government Defense Ministry Triples Scale of BIO-key Biometric DeploymentJuly 12, 2023 | finance.yahoo.comPaulding Ohio Hospital Deploys BIO-key’s PortalGuard® Cloud Platform to Manage Identity-Bound Biometric Authentication for Epic HyperdriveJuly 10, 2023 | finance.yahoo.comBIO-key Customers in Florida and Illinois Migrate Their Identity and Access Management to the Cloud with PortalGuard® IDaaSJune 26, 2023 | finance.yahoo.comJohnston Community College Deepens Partnership with BIO-key, Implementing its PortalGuard® IDaaS Identity and Access Management Cloud Solution to Meet New Digital Transformation GoalsJune 20, 2023 | finance.yahoo.comQuirk Auto Group selects BIO-key’s PortalGuard® Cloud Solution to Meet Updated GLBA Act Safeguards Rule Requirements to Protect Consumer DataJune 13, 2023 | finance.yahoo.comBIO-key Enhances PortalGuard IDaaS Admin Panel to Better Serve MSPs and MSSPsJune 13, 2023 | finance.yahoo.comBIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its Q1’23 Form 10-Q with SECJune 12, 2023 | finance.yahoo.comBIO-key Partners with Savvy Info. Tech to Offer Powerful Identity and Access Management Solutions in Ethiopia’s Fast-Growing EconomyJune 12, 2023 | finance.yahoo.comBIO-key Partners with Savvy Info. Tech to Offer Powerful Identity and Access Management Solutions in Ethiopia’s Fast-Growing EconomyJune 8, 2023 | baystreet.caBio-Key Vaults on Iowa ConnectionJune 8, 2023 | finance.yahoo.comUniversity of Iowa Hospitals and Clinics Secure Access to Epic Hyperdrive with BIO-key PortalGuard® and Identity-Bound BiometricsJune 5, 2023 | msn.comBIO-key integrate with AWS Partner Network to build IAM solutions in EMEAJune 5, 2023 | finance.yahoo.comBIO-key Leverages AWS Partner Network to Build Identity and Access Management (IAM) Solutions in Europe, the Middle East and AfricaMay 25, 2023 | finance.yahoo.comBIO-key Unveils PortalGuard® Feature Enhancements Including Support for MacOS Multi-Factor Authentication (MFA) for EnterpriseMay 22, 2023 | finance.yahoo.comWood County, OH Deploys Flexible Multi-Factor Authentication Security with PortalGuard® Identity and Access Management Cloud PlatformSee More Headlines Receive BKYI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter. Email Address BKYI Company Calendar Last Earnings8/14/2023Today9/27/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Prepackaged software Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:BKYI CUSIPN/A CIK1019034 Webwww.bio-key.com Phone(732) 359-1100Fax732-359-1101Employees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,910,000.00 Net Margins-117.65% Pretax Margin-132.35% Return on Equity-122.43% Return on Assets-64.97% Debt Debt-to-Equity Ratio0.07 Current Ratio1.36 Quick Ratio0.66 Sales & Book Value Annual Sales$7.02 million Price / Sales0.72 Cash FlowN/A Price / Cash FlowN/A Book Value$0.63 per share Price / Book0.87Miscellaneous Outstanding Shares9,260,000Free Float8,209,000Market Cap$5.06 million OptionableNot Optionable Beta1.05 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Michael W. DePasquale (Age 68)Chairman & CEO Comp: $296.83kMr. Kwok Fong Wong (Age 60)MD of Hong Kong & Vice-Chairman Ms. Mira K. LaCous (Age 61)Chief Technology Officer Comp: $224.3kMr. James David Sullivan (Age 56)Sr. VP of Strategy & Compliance and Chief Legal Officer Comp: $367.49kMs. Cecilia C. Welch (Age 63)Chief Financial Officer Mr. Akintunde Carlton JejeManaging Director of AfricaMr. Alex RochaManaging Director of EMEAMr. Mark CochranPres of PortalGuardMore ExecutivesKey CompetitorsTaopingNASDAQ:TAOPWaveDancerNASDAQ:WAVDGSE SystemsNASDAQ:GVPDataseaNASDAQ:DTSSAmesiteNASDAQ:AMSTView All Competitors BKYI Stock - Frequently Asked Questions How have BKYI shares performed in 2023? BIO-key International's stock was trading at $0.5851 at the beginning of the year. Since then, BKYI stock has decreased by 6.7% and is now trading at $0.5461. View the best growth stocks for 2023 here. Are investors shorting BIO-key International? BIO-key International saw a increase in short interest in September. As of September 15th, there was short interest totaling 18,300 shares, an increase of 195.2% from the August 31st total of 6,200 shares. Based on an average trading volume of 25,100 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.2% of the company's stock are sold short. View BIO-key International's Short Interest. When is BIO-key International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our BKYI earnings forecast. How were BIO-key International's earnings last quarter? BIO-key International, Inc. (NASDAQ:BKYI) issued its quarterly earnings data on Monday, August, 14th. The technology company reported ($0.16) EPS for the quarter. The technology company earned $1.93 million during the quarter. BIO-key International had a negative net margin of 117.65% and a negative trailing twelve-month return on equity of 122.43%. What other stocks do shareholders of BIO-key International own? Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO). What is BIO-key International's stock symbol? BIO-key International trades on the NASDAQ under the ticker symbol "BKYI." How do I buy shares of BIO-key International? Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is BIO-key International's stock price today? One share of BKYI stock can currently be purchased for approximately $0.55. How much money does BIO-key International make? BIO-key International (NASDAQ:BKYI) has a market capitalization of $5.06 million and generates $7.02 million in revenue each year. The technology company earns $-11,910,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis. How can I contact BIO-key International? BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The official website for the company is www.bio-key.com. The technology company can be reached via phone at (732) 359-1100, via email at bkyi@catalyst-ir.com, or via fax at 732-359-1101. This page (NASDAQ:BKYI) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIO-key International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.